Potential Benefits Visceral fat reduction: Meaningful reduction in visceral adipose tissue, measurable after about 36 months in HIV-associated lipodystrophy [3]
Research data from preclinical settings suggests BPC-157's potential to upregulate growth hormone (GH) receptor expression
Physicians who prescribe it do so entirely off-label, accepting medicolegal risk and the burden of informed consent
Second, standardized and objective biomarkers for clinical evaluation remain underdeveloped, with current antiaging assessments often conflating subjective perceptions with measurable outcomes
Some people report mild side effects, like dizziness, nausea, or irritation at the injection site
Your provider may adjust to a maintenance protocol to sustain results long-term